ChanRx
3 articles about ChanRx
-
ChanRx's Phase 2b Study Of Vanoxerine Shows Strong Safety And Statistically Significant Efficacy Signals For Treatment Of Atrial Fibrillation
11/18/2013
-
ChanRx To Present Results Of Phase IIb Study In Atrial Fibrillation At The 2013 American Heart Association Scientific Sessions
11/12/2013
-
ChanRx Secures Series A Funding
11/21/2011